Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 4,817

Document Document Title
WO/2018/131989A1
The present invention relates to a composition for photodynamic therapy of cancer diseases using a gene expressing a fluorescent protein and a photosensitizer, and a photodynamic therapy method using the same. More specifically, the pres...  
WO/2018/128360A1
The present invention relates to a biocompatible photothermal composition that can be used in various fields including the treatment of cancer and skin diseases.  
WO/2018/126322A1
An apparatus, method, and use for ultrasound mediated microbubble delivery of pharmaceutical compositions to pulmonary tissue are provided. The pulmonary ultrasound apparatus includes an ultrasound signal generator for generating ultraso...  
WO/2018/121585A1
A nanoassembly of a hypocrellin derivative, prepared by using a hypocrellin derivative and an amphiphile as precursors, and utilizing the self-assembly property between the amphiphile and the hypocrellin molecule to obtain the nanoassemb...  
WO/2018/121674A1
Provided is a method by using infrared laser in a particular band to irradiate skin for significantly enhancing the biological effect generated by an exogenous RNA sequence after the sequence passes into skin. The biological effect of a ...  
WO/2018/126277A1
A method of preventing damage to non-neoplastic, e.g. healthy cells, by irradiating the non-neoplastic cells with a low-dose radiation is provided. The method initiates a protective cellular response which prevents later damage to non-ne...  
WO/2018/126280A1
The present invention provides a method of preventing damage to non-neoplastic cells i.e. healthy cells by irradiating with a low-dose radiation to the non-neoplastic cells, wherein the low-dose radiation is used to initiate a protective...  
WO/2018/120671A1
Disclosed are a liposome containing an azobenzene derivative and a preparation method therefor and the use thereof. The azobenzene derivative, phospholipid and cholesterol in the liposome have a molar ratio of 1-2 : 1-2 : 1-2. The liposo...  
WO/2018/114988A1
The present invention relates to the medical field, in particular to the enhancement of brain performances and to the treatment of pathological stress. More specifically the present invention relates to a nanoparticle or nanoparticles' a...  
WO/2018/112575A1
The present invention relates to a process for producing a nanocomposite containing graphene oxide and silica nanoparticles as a hydrophobic drug carrier. The present invention also relates to the nanocomposite produced or not produced b...  
WO/2018/114945A1
The present invention relates to the medical field, in particular to the treatment of neurological disorders. More specifically the present invention relates to a nanoparticle or nanoparticles' aggregate for use in prevention or treatmen...  
WO/2018/112666A1
The present disclosure provides biophotonic compositions comprising a lichen extract and a carrier medium wherein the lichen extract comprises at least one chromophore. The lichen extract is preferably derived from a lichen selected from...  
WO/2018/115023A1
The present invention relates to the medical field, in particular to the modulation of electrical polarization of neurons. More specifically the present invention relates to a nanoparticle or nanoparticles' aggregate for use for modulati...  
WO/2018/103759A1
Disclosed are a self-assembled drug-loading system containing a hydrophilic phototherapeutic drug and a hydrophobic chemotherapeutic drug, a preparation method therefor and the use thereof for preparing an anti-tumour drug. The self-asse...  
WO/2018/102765A1
Provided are methods of producing cobalt nanoparticles (Co NPs). The methods include combining a cobalt salt, a capping agent, and a reducing agent, under Co NP synthesis conditions including a temperature selected to produce cobalt nano...  
WO/2018/102711A1
Various aspects of the disclosure relate to methods and systems for extracting plant oil from plant material. A system may comprise a microwave emitter, an extraction chamber, and a cooling chamber. Microwave radiation emitted by the mic...  
WO/2018/098315A1
In alternative embodiments, provided are compositions, including products of manufacture and kits, and methods, for remotely-controlled and non-invasive manipulation of intracellular nucleic acid expression, genetic processes, function a...  
WO/2018/095017A1
A targeted photothermal black phosphorus nano preparation, comprising: a black phosphorus nano sheet, a polyethylene glycol adsorbed onto a surface of the black phosphorus nano sheet by electrostatic attraction, and a folic acid linked t...  
WO/2018/086243A1
The present invention relates to a pH-sensitive ketal-linked cholesterol-difluoro-boraindacene derivative, a preparation method therefor and medical application thereof, and in particular, to a cholesterol-difluoro-boraindacene derivativ...  
WO/2018/086242A1
The present invention relates to a pH-sensitive ketal-linked cholesterol-silicon phthalocyanine complex, a preparation method therefor and medical application thereof, and in particular, to a silicon phthalocyanine complex represented by...  
WO/2018/086241A1
The present invention relates to a pH-sensitive ketal-linked cholesterol-zinc phthalocyanine coordination complex and a preparation method therefor and application thereof in medicine. In particular, the present invention relates to the ...  
WO/2018/089972A1
The present invention provides an implant comprising an isotope capable of producing a dose of ionizing radiation upon exposure to a flux of low energy neutrons, and a method in which, after implantation, the implant is exposed to a flux...  
WO/2018/085630A2
Ironized viral particles such as ironized adeno-associated viral particles, which may carry a photosensitizer such as aKillerRed protein, and uses thereof in light-triggered virotherapy against tumor.  
WO/2018/085630A3
Ironized viral particles such as ironized adeno-associated viral particles, which may carry a photosensitizer such as aKillerRed protein, and uses thereof in light-triggered virotherapy against tumor.  
WO/2018/081262A1
Targeting molecules that when circulated within the bloodstream tend to bind to malignant cells and minimize attachment to healthy tissue cells and benign tumor cells. The targeting molecule is designed to be detectable such that it can ...  
WO/2018/076526A1
Provided are a novel chlorin e6 derivative and pharmaceutically-acceptable salts thereof, a preparation method therefor, and an application thereof, relating to the technical field of pharmacy. The chlorin e6 derivative ether-based amino...  
WO/2018/076011A1
This disclosure provides systems and methods for providing a controlled thermal treatment to a target medium. A preconditioning process is performed to establish a thermal gradient within the target medium. Following the establishment of...  
WO/2018/069536A1
The present invention provides TPCS2a, gemcitabine and optionally another cytotoxic agent, preferably cisplatin, for use in a method of treating a cholangiocarcinoma in a human patient comprising a photochemical internalization method. R...  
WO/2018/071837A1
Embodiments of the disclosure concern methods and compositions for treating cancer in an individual that includes combination therapy comprising radiofrequency therapy and immunotherapy. In specific embodiments, utilization of the radiof...  
WO/2018/065860A1
The present disclosure relates to quantum dot nanoparticles conjugated to ligands, and in particular quantum dot nanoparticles wherein each nanoparticle is conjugated to a polymenzable ligand. The present disclosure also relates to metho...  
WO/2018/064961A1
Provided herein is a new generation of PDT agents based on porphyrin-lanthanide complexes with specific functional groups which can specifically localize on particular tumors, and their PDT processes can be monitored via NIR emission fro...  
WO/2018/064963A1
Provided is use of a fullerene structure comprising at least one active ingredient selected from a group consisting of an oil-soluble hollow fullerene, an oil-soluble metallofullerene, a composition of the oil-soluble hollow fullerene an...  
WO/2018/061201A1
A phototherapy system according to the present invention includes a photosensitizer that selectively accumulates at a lesion in a living body, and a phototherapy device. A phototherapy device (10) includes a light irradiation part (3) th...  
WO/2018/060437A1
The present invention is generally directed to improvements in the treatment of cancer and diseases in the central nervous system. A new drug delivery system is provided, method for producing it and medical uses.  
WO/2018/053646A1
The present document describes methods of using compositions for inhibiting biofilm formation, or disrupting existing or developing biofilms in a subject, which composition comprises at least one chromophore and a pharmacologically accep...  
WO/2018/053645A1
The present document describes methods and uses of compositions which comprise at least one photoactivator or chromophore in association with a pharmacologically acceptable carrier for use in reducing pain that is associated with a medic...  
WO/2018/053641A1
The present disclosure relates to methods for reducing scarring of wounds. The methods comprising topically applying on the wound a biophotonic composition followed by illumination of the applied biophotonic composition with actinic ligh...  
WO/2018/052846A1
Systems and methods for capture, recording, and regeneration of subtle energy resonance signals are described herein. A system for capturing and recording the signals may include an antenna array disposed within an electromagnetic shield...  
WO/2018/045284A1
The present disclosure includes system, methods, and kits relating to creating a second structure with a plurality of first structures at a target site inside or adjacent to a host object. The methods include the step of generating a fie...  
WO/2018/044912A1
The invention provides compositions and kits including at least one nucleic acid or polypeptide molecule encoding for a mutant CoChop protein. Methods of the invention include administering a composition comprising a mutant CoChop to a s...  
WO/2018/038025A1
Provided is a near infrared light emitting material containing a porphyrin compound that is amorphous and is represented by general formula (I).  
WO/2018/036078A1
Disclosed is a method for preparing a solution containing ligand-bonded gold nanoclusters. The method comprises the following steps: providing an aqueous solution containing a gold precursor, a base and a ligand; performing a reduction r...  
WO/2018/029862A1
The efficacy of an antitumor aqueous solution that can be generated by plasma irradiation varies according to the plasma irradiation conditions, and more optimal plasma irradiation conditions depend on the type of tumor. Therefore, the p...  
WO/2018/031448A1
Embodiments of near- infrared light-cleavable heptamethine cyanine-based conjugates, particularly targeting agent-drug conjugates, according to Formula I and conjugate precursors are disclosed. The disclosed targeting agent-drug conjugat...  
WO/2018/026816A1
A phosphor-containing drug activator activatable from a Monte Carlo derived x-ray exposure for treatment of a diseased site. The activator includes an admixture or suspension of one or more phosphors capable of emitting ultraviolet and v...  
WO/2018/025165A1
A medicament comprising a parsley extract for use in the treatment and/or prevention of endometriosis is described. The medicament may also comprise an oleander extract.  
WO/2018/024716A1
The present invention refers to a process for preparing a salt solution comprising sodium chloride and extracts of parts of officinal plants, preferably extracts of olive tree leaves; the invention is further directed to the salt solutio...  
WO/2018/021138A1
Provided is a novel boron-containing compound. A compound represented by formula below is prepared and used. A black circle represents a B atom, and a white circle represents B-H; -R1 represents a group having 3-10 repeating sequences of...  
WO/2018/016014A1
The efficacy of an antitumor aqueous solution generatable by plasma irradiation varies according to plasma irradiation conditions, and appropriate plasma irradiation conditions depend on the type of tumor. Therefore, the present inventio...  
WO/2018/014111A1
There is provided methods, compositions and treatment regimens for treating cancer, or for inhibiting metastasis/recurrence of cancer in a patient using 1) a primary cancer treatment such as chemotherapy, and 2) within 12 to 120 hours po...  

Matches 1 - 50 out of 4,817